These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 216831

  • 1. Epstein-Barr virus antibodies in Sudanese patients with nasopharyngeal carcinoma: a preliminary report.
    Malik MO, Banatvala J, Hutt MS, Abu-Sin AY, Hidaytallah A, El-Hadi AE.
    J Natl Cancer Inst; 1979 Feb; 62(2):221-4. PubMed ID: 216831
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H, Nowak R, Donner A, Kunkel M, Gärtner L, Scholtz HJ.
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [Abstract] [Full Text] [Related]

  • 3. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba.
    Ruiz R, Gurtsevich V, Le Riverend E.
    Neoplasma; 1979 May; 26(2):125-31. PubMed ID: 224330
    [Abstract] [Full Text] [Related]

  • 4. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM, Mendoza Montero J, Expósito Hernández J, Salinero Hernández J, Esquivias López-Cuerpo J, Ballesteros García P.
    Acta Otorrinolaringol Esp; 1992 May; 43(1):31-6. PubMed ID: 1316136
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
    Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, Hassar M, Khyatti M.
    J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 9. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.
    Shimakage M, Ikegami N, Chatani M, Yoshino K, Sato T.
    Biken J; 1987 Jun 15; 30(2):45-51. PubMed ID: 2830879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma.
    Kottaridis SD, Goula I, Kiparissiadis P.
    Neoplasma; 1982 Jun 15; 29(3):327-31. PubMed ID: 6290911
    [No Abstract] [Full Text] [Related]

  • 13. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI, Henle W, Henle G, Ersoy F, Sanal O, Klein G, Yeğin O.
    Kroc Found Ser; 1985 Jun 15; 19():287-300. PubMed ID: 2999343
    [Abstract] [Full Text] [Related]

  • 14. Nasopharyngeal carcinoma and Epstein-Barr virus. III. The detection of anti-nuclear antibodies.
    Lynn TC, Hsu MM, Hsieh T, Tu SM, Hamajima K.
    Jpn J Exp Med; 1976 Oct 15; 46(5):289-95. PubMed ID: 189106
    [Abstract] [Full Text] [Related]

  • 15. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma.
    Tan RS, Li JS, Grill SP, Nutter LM, Cheng YC.
    Cancer Res; 1986 Oct 15; 46(10):5024-8. PubMed ID: 3019519
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
    Wilmes E, Wolf H, Deinhardt F, Naumann HH.
    Laryngol Rhinol Otol (Stuttg); 1981 Jan 15; 60(1):4-6. PubMed ID: 6261051
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody.
    Lynn T, Tu S, Hirayama T, Kawamura A.
    Jpn J Exp Med; 1973 Apr 15; 43(2):121-33. PubMed ID: 4352111
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.